Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

Canadian researchers say a blood test measuring immune response to gut bacteria could help predict Crohn’s disease years ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

AbbVie is paying $650 million for a dual-targeting immunotherapy from China’s RemeGen. Elsewhere, Alnylam missed an earnings ...

Investing.com - RBC Capital has reiterated an Outperform rating on Jazz Pharmaceuticals (NASDAQ:JAZZ) with a price target of $194.00, representing about 17% upside from the current price of $165.43.

Sinai Health researchers have shown a blood test that can predict Crohn's disease years before symptoms appear, opening the ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways IgA nephropathy is diagnosed through a combination of clinical ...

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...

A new, fast and easy test could revolutionize blood transfusions, giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after they sit for weeks in storage.